Kenya is spearheading Africa's health sovereignty by prioritizing local pharmaceutical and vaccine production, urging increased investment and collaboration to reduce reliance on external supply chains.

• Kenya is investing USD 60.8 million in a fill-and-finish vaccine facility and USD 248 million in an end-to-end manufacturing facility at Konza Technopolis.
• Key figures include Cabinet Secretary for Health Aden Duale, President John Dramani Mahama of Ghana, and representatives from organizations like the WHO and Gavi, the Vaccine Alliance.
• The push for local production aims to strengthen Africa's resilience against future health shocks, as highlighted at the Africa Forward Summit 2026.